Innovating Amid Uncertainty: Advancing Biotech in a Shifting Landscape
In today’s dynamic biotech environment, success requires navigating an intricate web of science, technology, markets, and regulation—all while pushing the boundaries of innovation. This panel brings together leading CSOs and industry experts to discuss how they balance high-risk, high-reward research with commercialization strategies, talent retention, and regulatory navigation. Join us to explore how emerging technologies, strategic partnerships, and evolving funding models are shaping the future of biotech and how organizations can move efficiently from discovery to patient impact.

Jacob Oppenheim
Venture Partner
RA Ventures

Adrian Bot
CSO and EVP R&D
Capstan Therapeutics

Shane Hegarty
CSO & Co-Founder
Axonis Therapeutics

Abhay Kini
Global Head of Egntye Life Sciences
Egnyte